Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
published in: American Heart Journal
date of publication: 2019-08-09
main subject: acute coronary syndrome
Cites articles
There is nothing here
Article - wd:Q90105849